Financials

  • Market Capitalization 263.98 M
  • Employee 152
  • Founded 2016
  • CEO N/A
  • Website www.entradatx.com
  • Headquarter Delaware, United States
  • FIGI BBG00MTSMC16
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-3.15
市销率
91.18

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
3414
IKT
Inhibikase Therapeutics, Inc. - Common Stock
2.06 USD+5.10%+0.98%+23.35%+14.44%271.99 M USD
3419
ALXO
ALX Oncology Holdings Inc. - Common Stock
2.00 USD+1.52%-15.25%+25.79%+325.53%269.13 M USD
3440
NAGE
Niagen Bioscience, Inc. - Common Stock
3.29 USD-5.19%-4.08%-6.53%-33.94%262.03 M USD
3459
SRZN
Surrozen, Inc. - Common Stock
21.88 USD-4.08%-4.87%-5.65%+162.98%254.03 M USD

新闻